> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Intraocular Lens for Cataract Surgery
- URL: https://www.fdaweb.com/fda-approves-intraocular-lens-for-cataract-surgery/
- Published: 2024-10-14T12:00:00.000Z
- Updated: 2026-09-14T14:43:56.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5157975

FDA has approved Bausch + Lomb’s EnVista Envy intraocular lens (IOL), which offers a “continuous range of vision with excellent dysphotopsia tolerance” for cataract patients, according to the company. Approval was based on clinical trial data from 332 subjects. “On average, 86% of patients reported little to no bothersomeness for dysphotopsia (glare, halo, starbursts), showing an impressive tolerance profile overall,” Bausch + Lomb says. “In a Canadian clinical study evaluating 110 subjects, 94% of patients reported little to no difficulty viewing close objects, and 93% were completely to moderately satisfied with their vision post-surgery.”

The IOL is indicated for “primary implantation in the capsular bag of the eye in adult patients for visual correction of aphakia with less than or equal to 1.0 D preoperative corneal astigmatism following removal of a cataractous lens to mitigate the effects of presbyopia by providing improved intermediate and near visual acuity, while maintaining comparable distance visual acuity to an aspheric monofocal IOL,” the company says.